Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease

Published:2016-11 Issue:11 Volume:14 Page:1593-1601.e2
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Amiot Aurelien^ORCID,Grimaud Jean-Charles,Peyrin-Biroulet Laurent,Filippi Jerome,Pariente Benjamin,Roblin Xavier,Buisson Anthony,Stefanescu Carmen,Trang-Poisson Caroline,Altwegg Romain^ORCID,Marteau Philippe,Vaysse Thibaud,Bourrier Anne,Nancey Stephane,Laharie David,Allez Matthieu,Savoye Guillaume,Moreau Jacques,Gagniere Charlotte,Vuitton Lucine,Viennot Stephanie,Aubourg Alexandre^ORCID,Pelletier Anne-Laure,Bouguen Guillaume,Abitbol Vered,Bouhnik Yoram,Amiot Aurelien,Gagniere Charlotte,Grimaud Jean-Charles,Peyrin-Biroulet Laurent,Zallot Camille,Bigard Marc-Andre,Filippi Jerome,Hebuterne Xavier,Pariente Benjamin,Nachury Maria,Desreumaux Pierre,Roblin Xavier,Del Tedesco Emilie,Buisson Anthony,Bommelaer Gilles,Stefanescu Carmen,Boureille Arnaud,Trang-Poisson Caroline,Altwegg Romain,Marteau Philippe,Dray Xavier,Carbonnel Franck,Seksik Philippe,Beaugerie Laurent,Cosnes Jacques,Sokol Harry,Landman Cecilia,Nancey Stephane,Boschetti Gilles,Laharie David,Poullenot Florian,Allez Matthieu,Gornet Jean-Marc,Baudry Clautilde,Savoye Guillaume,Moreau Jacques,Gagniere Charlotte,Vuitton Lucine,Koch Stephane,Viennot Stephanie,Aubourg Alexandre,Picon Laurence,Pelletier Anne-Laure,Sickersen Gaelle,Bouguen Guillaume,Abitbol Vered,Chaussade Stanislas,Bouhnik Yoram,Nahon Stephane,Winkfield Betsy,Brixi-Benmansour Hedia,Gincul Rodica,Barberis Jean-Christophe,Bonaz Bruno,Michiels Christophe,Zerbib Franck,de Beauregard Marie Bourrier,Locher Christophe,Davin-Couve Sophie,Poirette Armelle,Guillem Laurence,Stetiu-Mocanu Monica,Beorchia Sylvain,Al Qaddi Jawad

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference21 articles.

1. Currrent, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases;Amiot;Ther Adv Gastroenterol,2015

2. Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin;Feagan;N Engl J Med,2005

3. Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease;Fiorino;Expert Rev Clin Immunol,2010

4. Review article: anti-adhesion therapies for inflammatory bowel disease;Lobaton;Aliment Pharmacol Ther,2014

5. Vedolizumab as induction and maintenance therapy for ulcerative colitis;Feagan;N Engl J Med,2013

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review;Journal of Managed Care & Specialty Pharmacy;2024-09

2. Biologics in Focus: A Comprehensive Review of Current Biological and Small Molecules Therapies for Crohn’s Disease in the United Arab Emirates (UAE);Gastrointestinal Disorders;2024-07-07

3. Approach to loss of response to advanced therapies in inflammatory bowel disease;World Journal of Gastroenterology;2024-06-14

4. Vedolizumab in the treatment of Crohn's disease: A promising therapeutic approach;Drug Development Research;2024-06

5. Real-World Comparison of the Effectiveness between Ustekinumab and Vedolizumab in Patients with Ulcerative Colitis Exposed to at least One Anti-TNF Agent;Journal of Crohn's and Colitis;2024-05-14